Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 19, 2024 08:00 ET | Source: SIGA Technologies Inc.

SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®

NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human...
June 17, 2024 16:05 ET | Source: SIGA Technologies Inc.

SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States

NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on global health and infectious diseases, announced today an agreement to...
May 07, 2024 16:05 ET | Source: SIGA Technologies Inc.

SIGA Reports Financial Results for Three Months Ended March 31, 2024

Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 MillionCorporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies,...
May 01, 2024 17:00 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results

NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
April 01, 2024 16:05 ET | Source: SIGA Technologies Inc.

SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious disease, announced today that...
March 25, 2024 07:30 ET | Source: SIGA Technologies Inc.

SIGA Names Larry Miller General Counsel

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious diseases, announced the...
March 12, 2024 16:05 ET | Source: SIGA Technologies Inc.

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023

• Increased Product Sales to $131 Million in 2023 • Grew Pre-tax Operating Income to $84 Million in 2023 • Declared Today a Special Cash Dividend of $0.60 per Share • Corporate Update Conference...
March 12, 2024 07:30 ET | Source: SIGA Technologies Inc.

SIGA Declares Special Cash Dividend of $0.60 Per Share

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special...
March 05, 2024 07:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results

NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
January 22, 2024 07:30 ET | Source: SIGA Technologies Inc.

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem...